Singapore markets close in 2 hours 44 minutes
Straits Times Index
3,237.53 +12.08 (+0.37%) Nikkei
27,555.76 -130.64 (-0.47%) Hang Seng
19,341.67 +526.85 (+2.80%) FTSE 100
7,489.19 -32.20 (-0.43%) BTC-USD
16,808.65 -187.08 (-1.10%) CMC Crypto 200
394.25 -7.78 (-1.94%)
Swedish Orphan Biovitrum AB (publ) (B6E.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 05:15PM CET
| Previous close | 18.60 |
| Open | 18.67 |
| Bid | 19.00 x 76000 |
| Ask | 19.29 x 74000 |
| Day's range | 18.58 - 18.86 |
| 52-week range | 16.50 - 22.79 |
| Volume | |
| Avg. volume | 1 |
| Market cap | 5.83B |
| Beta (5Y monthly) | 0.43 |
| PE ratio (TTM) | 21.93 |
| EPS (TTM) | 0.86 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Swedish Orphan Biovitrum (BIOVF) Beats Q3 Earnings Estimates
Swedish Orphan Biovitrum (BIOVF) delivered earnings and revenue surprises of 16.67% and 2.26%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Are Medical Stocks Lagging Alimera Sciences (ALIM) This Year?
Here is how Alimera Sciences (ALIM) and Swedish Orphan Biovitrum (BIOVF) have performed compared to their sector so far this year.
- Zacks
Is Swedish Orphan Biovitrum (BIOVF) Stock Outpacing Its Medical Peers This Year?
Here is how Swedish Orphan Biovitrum (BIOVF) and CymaBay Therapeutics Inc. (CBAY) have performed compared to their sector so far this year.
© 2022 Yahoo. All rights reserved.
